GP vaccine hub

📋 Source: Australian Immunisation Handbook (immunisationhandbook.health.gov.au) & NCIRS (ncirs.org.au).
Your doctor or healthcare provider knows your history and circumstances — always follow their personalised advice over general information.

Every AskMyGP immunisation tool in one place — plus what's just changed and what's coming on the National Immunisation Program. Built for general practice and anchored on the NIP, ATAGI and the Australian Immunisation Handbook. Always confirm eligibility against the official schedule before you vaccinate.

Anchored on Immunisation Handbook NIP schedule NCIRS

📣 What's changed & what's coming

COVID-19 — moved to the NIPIn effect from 1 October 2026

COVID-19 vaccines moved from the stand-alone National COVID-19 Vaccine Program onto the National Immunisation Program — the same mechanism as flu, pneumococcal and RSV.
Free NIP-funded vaccination is now limited to adults 75+ (2 doses/year), adults 65–74, Aboriginal and Torres Strait Islander people 50–74, and adults 18–64 with severe immunocompromise (1 dose/year each). ATAGI: “recommended” doses are funded, “consider” doses are not — those patients can purchase privately.
Ordering, distribution and reporting are now managed through state/territory NIP arrangements. ATAGI statement issued 7 September 2026; Handbook chapter updated from 1 October 2026. Full reference: COVID-19 vaccine clinician guide.

Pneumococcal — 21vPCV (Capvaxive)From 1 July 2026

Capvaxive (21vPCV) replaces Prevenar 13 + Pneumovax 23 for adults on the NIP — a single, simplified schedule covering more strains.
Free on the NIP for adults ≥65, Aboriginal & Torres Strait Islander adults ≥25, and adults ≥18 with specified risk conditions.
The age thresholds drop (previously 70 / 50). See the Department of Health's adult pneumococcal program advice. Full reference: Adult pneumococcal (21vPCV / Capvaxive) clinician guide.

RSV — older adults (Arexvy)NIP since 15 May 2026

Arexvy is free on the NIP for all adults ≥75 and First Nations adults ≥60.
Single dose, protection across at least two seasons — no annual revaccination. Not for use in pregnancy.
NIP eligibility is linked to Medicare; brands aren't interchangeable. Reference: NCIRS RSV FAQs.

RSV — pregnancy & infantsYear-round / seasonal

Abrysvo (maternal) is funded for each pregnancy from 28 weeks gestation, offered year-round — the only RSV vaccine approved in pregnancy.
Nirsevimab (Beyfortus) for infants is funded through state/territory programs (seasonal), not the NIP — check your jurisdiction's program dates and eligibility.

🧰 Vaccine tools

✨ New — interactive calculators

🫁

Pneumococcal Eligibility Checker NEW

Am I due for Capvaxive (21vPCV) on the NIP? Age, ATSI, risk conditions — patient + clinician view with MBS notes.

🦠

Do I Need RSV Vaccine? NEW

Patient decision aid — 3–4 questions, then a personalised answer with what to say at their appointment.

📅

Vaccine Interval Calculator NEW

Pick two vaccines + date given — see same-day OK, minimum wait, or next earliest date.

For clinicians

💉

GP Vaccine Dashboard NEW

One patient profile — every vaccine's NIP status, MBS billing note and AIR reminder on one screen.

🩺

Vaccines by Medical Condition NEW

ATAGI recommendations and NIP funding for each risk condition (Dept of Health, Aug 2026).

💉

Vaccination Clinical Tool

NIP schedule reference for general practice.

🧬

COVID-19 Vaccine — Clinical Guide NEW

Current intervals & funding, plus the 1 Oct 2026 NIP transition.

🫁

RSV Vaccine — Clinical Guide

Arexvy, Abrysvo & nirsevimab — eligibility & product selection.

🫁

Adult Pneumococcal Guide (21vPCV)

Clinician reference — Capvaxive schedule, catch-up, co-admin.

🦠

Mpox Vaccine — Clinical Guide

JYNNEOS eligibility & state supply.

🔀

Co-administration Checker

Which vaccines can be given together.

🔬

Is This Vaccine Live?

Quick lookup — the key input for the 4-week rule.

For patients

🧑

Adult Vaccination Checker

What's funded for adults by age & risk.

🧒

Child Immunisation Schedule

The NIP childhood schedule, plainly.

🧬

COVID-19 Vaccine — Patient Guide NEW

Who's funded now, what changed from 1 Oct 2026.

🫁

RSV Vaccine — Patient Guide

Who needs it, what it costs, what to expect.

🫁

New Pneumococcal Vaccine (Capvaxive) 2026

What changed on 1 July — patient explainer.

🤧

Free Flu Vaccine — Who Qualifies

NIP-funded influenza eligibility.

🌟

Shingles Vaccine (Shingrix) Guide

Eligibility, cost, side effects.

📚 Authoritative references

NIP schedule →Department of Health Immunisation Handbook →ATAGI / Dept of Health NCIRS →Fact sheets & FAQs

⚠️ Immunisation schedules change — typically each January and mid-year. This hub reflects the NIP as at 1 October 2026; the pneumococcal change applied from 1 July 2026, and the COVID-19 transition to the NIP took effect on 1 October 2026 (see the ATAGI statement of 7 September 2026). Always confirm current eligibility against the Australian Immunisation Handbook and your state/territory program before vaccinating. This is information for health professionals, not clinical advice for an individual patient.

How this stays neutral. This hub is GP-authored and anchored on ATAGI, the NIP and NCIRS. It's funded by display ads, not by vaccine manufacturers, and inclusion of any tool or reference is never endorsement of a product. See our editorial independence policy.

💉

Vaccination Catch-Up

Behind-schedule catch-up calculator.

🧬

COVID-19 Hub

Eligibility, NIP transition & clinical guide.

💉

Vaccination Clinical Tool

Schedule & dosing reference.